Health and Insurance Information

Is In That Place A Pill To Brand Y'all Alive Longer? The Hope-3 Lawsuit As Well As The Hype That Volition Sure Follow ...

Today inward the New England Journal of Medicine (NEJM) an article has appeared reporting the results of the Heart Outcomes Prevention Evaluation-3 (HOPE-3)trial. Exciting simplifications are certain to follow inward the news. If you lot would similar to halt reading now, the response to the inquiry posed inward the championship is in all likelihood no.

The question:

For many years researchers receive got discussed the possibility of a creating a pill that mightiness comprise several kinds of medication that would trim people's jeopardy of dying of cardiovascular disease. It is an attractive thought. Since cardiovascular illness is the major drive of decease globally, reducing that jeopardy has the potential to vastly trim decease too disability. Originally nosotros idea that a suitable "polypill" mightiness comprise something to lower the blood pressure, something to lower cholesterol too something to trim the jeopardy of blood clots. Many studies receive got looked at the mortality benefits of diverse blood pressure level pills, cholesterol lowering strategies too anti-clotting drugs too nosotros receive got constitute that some of them assistance some people to some extent too some drive some people problems. Drat. So complex.

The history:

The master HOPE trial looked at a blood pressure level pill (ramipril) which was added to whatever other medication a grouping of people at high jeopardy of cardiovascular illness were taking. It lowered the jeopardy of catch attack, stroke too decease significantly plenty that the study was stopped early on too drugs inward the ramipril shape (Ace inhibitors) were aggressively prescribed, particularly for patients alongside diabetes, in all likelihood to expert effect.

The HOPE-2 trial looked at using vitamins to trim homocysteine levels, which appeared to endure a important jeopardy constituent for catch assail too stroke. The studied doses of vitamin B6, B12 too folate did non trim whatsoever of the outcomes they looked at. HOPE-2 was dashed.

In 2007 HOPE-3 began, looking at a combination of blood pressure level medication too cholesterol medication, specifically to trim decease from catch assail or stroke, novel catch failure, cardiac arrest or non-fatal catch assail or angina. The study was performed inward academic medical centers all over the world, including the US, Europe, mainland People's Republic of China too India, South Africa too Southeast Asia. Over 14,000 patients were enrolled, express to men 55 too over too women 65 too over alongside intermediate cardiovascular jeopardy (calculated at virtually 1% per year). Women 60-65 years of historic menstruum were eligible if they had i of several specific jeopardy factors, including glucose intolerance, smoking too high waist to hip ratios. These were people who had never had catch problems or strokes.

Drug society involvement:

Astra Zeneca helped fund this study along alongside the Canadian Institutes of Health Research. The cholesterol too blood pressure level medication used inward the study was on patent too sold past times Astra Zeneca. The cholesterol pill was rosuvastatin (Crestor) too the blood pressure level medication was candesartan/hydrochlorothiazide (Atacand/HCT). There were many drugs to select from inward the categories of effective blood pressure level reducers too statin cholesterol medication, some of which would receive got been inexpensive too generic. The drugs they did select are straight off generic but non yet cheap. I suspect Astra Zeneca hoped the study would receive got ended inward fourth dimension for them to reap fiscal benefits equally their item drug proved miraculously effective, or that the combination of the drugs could endure made into a novel formulation that would extend their marketplace share.

So what happened? Getting to the point.

First in that location was a run-in phase. The 14,000+ patients were given the study drugs too virtually 2000 of them dropped out because they didn't tolerate them or didn't desire to participate anymore. 12,000 patients were left. Of these virtually 3000 took placebo pills, 3000 took the blood pressure level pills only, 3000 took the cholesterol pill entirely too 3000 took both blood pressure level too cholesterol medication. After virtually 5.5 years, the patients taking blood pressure level medication did non receive got a significantly lower jeopardy of death, catch assail or stroke or the other cardiovascular outcomes. The patients taking cholesterol medication did receive got a reduced jeopardy of decease too cardiovascular outcomes. Taking both blood pressure level medication too cholesterol medication was no meliorate than only taking the cholesterol medication.

How big was the lawsuit too how much does this cost?

The article quotes a jeopardy ratio of 0.71 for patients taking the combination medication, pregnant that the medicated patient has vii tenths the jeopardy of a bad outcome of the unmedicated patient. The raw numbers are agency to a greater extent than interesting. After virtually 5 too a one-half years of taking the combination of drugs or placebo, 163 patients inward the active drug grouping had died too 178 of the placebo grouping had died, a deviation of 15. At the acquaint damage of these drugs, virtually $280 per month, it would damage virtually $3.7 i yard k per life saved, which is pretty steep. Just taking the cholesterol medication, which is truly the entirely i that had a positive effect, would damage virtually $2.6 i yard k per life saved. If in that location were drugs on a $4 a calendar month invention that did the same affair  we mightiness larn downwards to a real reasonable damage of $53,000, assuming no other associated costs similar doc visits or lab testing (which is non a fair assumption.) Death is non the entirely affair nosotros aid about, of course, but other differences, such equally numbers of hospitalizations, were non much to a greater extent than impressive when I reviewed the supplemental data.

How virtually side effects?

To laid about with, 2,000 of 14,000 patients did non similar or tolerate the study drugs, too hence some of them in all likelihood had intolerable side effects. During the study, however, in that location weren't many of import side effects except a fleck to a greater extent than dizziness inward the patients on blood pressure level medication, which plainly didn't create them much expert anyway. There was some musculus pain, but patients on placebo also had that. The dose of the cholesterol pill was real low, which mightiness receive got explained the pretty awesome side lawsuit profile. Also the patients most bothered past times side effects in all likelihood dropped out inward the run-in period. By the destination of the study entirely virtually 70% of patients were silent taking the prescribed drugs, too hence in that location may receive got been intolerance that was non reported. There was no excess of evolution of diabetes, mayhap because of the real depression statin dose. Good studies receive got shown to a greater extent than evolution of diabetes inward statin users, but doses are oft significantly higher.

Other interesting findings from the supplemental data:

I was real pleased that the NEJM published a good written summary of information that didn't larn discussed inward the article. There were some truly weird things that showed up.

  1. South Asians too to some extent Chinese subjects did non receive got nigh equally much create goodness from the study drugs equally did subjects of European descent. 
  2. Stroke jeopardy was truly higher for patients alongside borderline high blood pressure level when they were treated alongside the blood pressure level lowering drugs, though reduced for patients alongside higher too lower blood pressures. 
  3. Patients alongside the highest cholesterol levels (LDL greater than 141, hateful of 166) did non create goodness from handling alongside cholesterol lowering drugs. That's truly foreign too counterintuitive.

Bottom line?

We receive got non discovered a pill yet that volition brand everyone alive longer. Taking a statin drug which lowers cholesterol (who knows if that's the of import effect) may lower your jeopardy of cardiovascular illness or death, but you lot postulate to receive got it a long fourth dimension to brand a pocket-sized deviation too nosotros aren't certain which i is most effective. Most people who receive got statin drugs (Lipitor, Crestor/rosuvastatin etc.) for primary prevention (meaning they haven't had catch attacks or strokes) volition non create goodness from them. Low doses of Crestor/rosuvastatin commonly receive got a depression jeopardy of side effects. Treating normal or slightly high blood pressure level alongside depression dose candesartan/HCTZ doesn't trim the jeopardy of catch attacks, strokes or cardiovascular death. Navigating the pros too cons of all of these pills too potions is neither obvious nor elementary too is best done alongside a doc who you lot know too trust.



Post a Comment